The, Shanghai Pharma and SoftBank China Venture Capital-backed O2O medical services operator, has secured fresh funding from investors including Sinocare.

China-based digital hospital and drugstore operator Shanghai Pharma Health (SPH) Commerce completed an RMB1.03bn ($160m) series B round last month featuring diabetes management technology provider Sinocare, Sina Finance has reported. JIC Investment, a vehicle for investment firm China Jianyin Investment, co-led the round with local government-backed Shanghai Biomedical Industrial Equity Investment Fund. It included Ample…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.